<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02898909</url>
  </required_header>
  <id_info>
    <org_study_id>JFO_2015_44</org_study_id>
    <nct_id>NCT02898909</nct_id>
  </id_info>
  <brief_title>Comparison of Two Fragmentation Modalities in Femtosecond Laser-assisted Cataract Surgery</brief_title>
  <acronym>SLICES</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Femtosecond laser-assisted cataract surgery consists in nuclear lens fragmentation, followed
      by ultrasound phacoemulsification of nuclear lens, which is then removed.

      It can be assumed that fragmenting the nuclear lens in more pieces could facilitate the
      post-laser ultrasound phacoemulsification to extract the lens, with a lesser amount of
      ultrasonic energy.

      The decrease of ultrasonic energy delivered during cataract surgery is beneficial to the
      patient because it optimizes the vitality of corneal endothelial cells, which ensure corneal
      transparency.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Major inclusion difficulties
  </why_stopped>
  <start_date type="Actual">November 15, 2016</start_date>
  <completion_date type="Actual">December 10, 2019</completion_date>
  <primary_completion_date type="Actual">December 21, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>energy delivered for lens nucleus aspiration during phacoemulsification</measure>
    <time_frame>approximatively 15 minutes</time_frame>
    <description>ultrasound power delivered (measured in Hertz)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>16 pieces fragmentation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>8 pieces fragmentation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nuclear lens fragmentation in 8 pieces</intervention_name>
    <arm_group_label>8 pieces fragmentation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nuclear lens fragmentation in 16 pieces</intervention_name>
    <arm_group_label>16 pieces fragmentation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient aged ≥ 18 years old

          -  first Femtosecond Laser-assisted Cataract Surgery scheduled

          -  cataract density ≥ 3 according to the lens opacities classification system (LOCS)

        Exclusion Criteria:

          -  corneal guttata, uncontrolled glaucoma

          -  shallow depth of anterior chamber

          -  patient's refusal to participate in the study

          -  pregnant or breast feeding patient

          -  patient under legal protection

          -  no health coverage
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Luc FEBBRARO, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation OPH A de Rothschild</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fondation Opthalmologique A de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>September 8, 2016</study_first_submitted>
  <study_first_submitted_qc>September 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2016</study_first_posted>
  <last_update_submitted>December 10, 2019</last_update_submitted>
  <last_update_submitted_qc>December 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>femtosecond laser-assisted cataract surgery</keyword>
  <keyword>nuclear lens fragmentation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

